Search This Blog

Thursday, May 7, 2020

Puma Biotechnology EPS beats by $0.48, beats on revenue

Puma Biotechnology (NASDAQ:PBYI): Q1 Non-GAAP EPS of -$0.20 beats by $0.48; GAAP EPS of -$0.43 beats by $0.34.
Revenue of $51.2M (-48.3% Y/Y) beats by $6.78M.
Shares +8.81%.
https://seekingalpha.com/news/3571570-puma-biotechnology-eps-beats-0_48-beats-on-revenue

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.